Hussain Lalani, M.D., M.P.H., M.Sc.

Hussain Lalani is a board-certified primary care internist and health policy researcher at Brigham and Women’s Hospital and Harvard Medical School. His research focuses on understanding the challenges and inequities patients face in accessing affordable prescription drugs and evaluating the impact of federal and state policies on health. His work is published broadly, including in JAMA, BMJ, and the Annals of Internal Medicine. In 2022, he was selected as a STAT Wunderkind. He is passionate about science communication and policy dissemination and frequently writes in the lay press on pressing issues of health policy, public health, and health misinformation. Dr. Lalani serves on the national steering committee of Doctors for America’s Drug Affordability Action Team. He is the Co-Founder of #ThisIsOurShot and VacunateYa, two national grassroots organizations that empower medical professionals to share accurate health information on social media and to combat misinformation. You can follow him on Twitter @DrHussainL.
Dr. Lalani is a first-generation Muslim American from Dallas, Texas. He practices primary care at the Phyllis Jen Center for Internal Medicine. He graduated from the Harvard General Internal Medicine fellowship at Brigham and Women's Hospital and trained in internal medicine at UT Southwestern Medical Center and Parkland Hospital. He earned his undergraduate degree (B.S.) in neuroscience and global health from Duke University, his medical degree (M.D.) from Duke School of Medicine, his public health degree (M.P.H.) from Johns Hopkins Bloomberg School of Public Health (M.P.H.), and his health policy degree (M.Sc.) from the Harvard T.H. Chan School of Public Health.
Dr. Lalani is a first-generation Muslim American from Dallas, Texas. He practices primary care at the Phyllis Jen Center for Internal Medicine. He graduated from the Harvard General Internal Medicine fellowship at Brigham and Women's Hospital and trained in internal medicine at UT Southwestern Medical Center and Parkland Hospital. He earned his undergraduate degree (B.S.) in neuroscience and global health from Duke University, his medical degree (M.D.) from Duke School of Medicine, his public health degree (M.P.H.) from Johns Hopkins Bloomberg School of Public Health (M.P.H.), and his health policy degree (M.Sc.) from the Harvard T.H. Chan School of Public Health.
Back to PORTAL Research Team
Program On Regulation, Therapeutics And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics 1620 Tremont Street, Suite 3030 Boston, MA 02120 |